Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003096 · ClinicalTrials.gov registry record
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 88
- Enrollment target
NCT00003096 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 88 participants.
The verdict
NCT00003096 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
RATIONALE: Analyzing the number and structure of genes found in a child's cancer cells may help doctors improve methods of diagnosing and treating children with brain tumors. PURPOSE: This clinical trial is studying the number and structure of genes in cancer cells of children with brain tumors.
Interventions
- GENETIC cytogenetic analysis
- GENETIC fluorescence in situ hybridization
- GENETIC comparative genomic hybridization
- GENETIC DNA ploidy analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 1996-12 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003096
The ClinicalTrials.gov registry entry for NCT00003096 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which cytogenetic analysis is the first listed.
NCT00003096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003096 about?
NCT00003096 is a clinical study titled "Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors". RATIONALE: Analyzing the number and structure of genes found in a child's cancer cells may help doctors improve methods of diagnosing and treating children with brain tumors. PURPOSE: This clinical trial is studying the number and structure of genes in cancer cells of children with brain tumors.
What is the current status of trial NCT00003096?
This trial is currently completed. The enrollment target is 88 participants. The study started on 1996-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00003096?
The interventions under investigation include: cytogenetic analysis (GENETIC), fluorescence in situ hybridization (GENETIC), comparative genomic hybridization (GENETIC), DNA ploidy analysis (GENETIC).
Who is sponsoring clinical trial NCT00003096?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.